ОбзорГрафикПрофильОсновная статистикаФинансовые показателиТехническийНовости
Деривативы
TraderScreen

NEXI/  IT0005366767  /

Euronext Milan
13.11.2024  17:36:41 Изменение -0.046 Объем сделки Бид3:02:24 Предложение3:02:24 Рыночная капитализация Дивидендная доходность Коэффициент Цена/Доход
5.518EUR -0.83% 3.56 млн
Оборот: 19.68 млн		 5.474Величина цены спроса: 100 5.600Величина цены предложения: 9,500 7.24 млрдEUR - -
GlobeNewswire 25.06 Worthington Enterprises Increases Quarterly Dividend by 6.25%
GlobeNewswire 12.06 Worthington Enterprises Schedules Fourth Quarter 2024 Earnings Call for June 26
GlobeNewswire 03.06 Worthington Enterprises Completes Acquisition of Hexagon Ragasco
GlobeNewswire 24.10.2023 NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes
GlobeNewswire 19.10.2023 NexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meeting
GlobeNewswire 18.10.2023 NexImmune Announces 1-for-25 Reverse Stock Split
GlobeNewswire 29.09.2023 Calian Launches Digital Health Portfolio of Products and Services
GlobeNewswire 28.09.2023 Northland Power Announces Financial Close of the 1.0 GW Hai Long Offshore Wind Project in Taiwan Fin...
GlobeNewswire 31.08.2023 NexImmune Announces Workforce Reduction to Enable Continued AIMTM Nanoparticle Platform Development ...
GlobeNewswire 17.03.2022 NexImmune and Zephyr AI Announce a Strategic Partnership in Oncology for Target Discovery and Valida...
GlobeNewswire 14.03.2022 NexImmune Announces Melanoma Research Collaboration with NYU Langone’s Perlmutter Cancer Center
GlobeNewswire 10.03.2022 NexImmune to Present at the Barclays 2022 Global Healthcare Conference
GlobeNewswire 09.03.2022 NexImmune Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
GlobeNewswire 17.02.2022 NexImmune Appoints Kristi Jones as Chief Executive Officer and Member of the Board of Directors
GlobeNewswire 05.01.2022 NexImmune Announces Formation of Autoimmune and Infectious Diseases Scientific Advisory Board
GlobeNewswire 12.12.2021 NexImmune Announces Preliminary Phase 1/2 NEXI-002 Results in Patients with Multiple Myeloma
GlobeNewswire 12.11.2021 NexImmune Reports Third Quarter 2021 Financial Results and Provides Business Updates
GlobeNewswire 08.11.2021 NexImmune to Announce Third Quarter 2021 Financial Results and Provide Corporate Update on November ...
GlobeNewswire 03.11.2021 NexImmune to Present at The Society for Immunotherapy of Cancer 36th Anniversary Annual Meeting
GlobeNewswire 20.10.2021 Bottomline Appoints Three New Directors to Board of Directors
GlobeNewswire 27.09.2021 NexImmune to Present at the 2021 Cantor Virtual Global Healthcare Conference
GlobeNewswire 16.09.2021 SBM Offshore completes US$1.6 billion financing of Sepetiba
GlobeNewswire 10.09.2021 NexImmune to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
GlobeNewswire 18.08.2021 Aite-Novarica Group Announces Winners of the 2021 Digital Wallet Innovation Awards
GlobeNewswire 09.08.2021 NexImmune Reports Second Quarter 2021 Financial Results and Provides Business Updates